Skip to main content

Table 1 Demographic and baseline data of the study group

From: NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy

Item

Descriptive

1. Age “years” mean ± SD (range)

50.66 ± 9.80 (27.0–69.0)

2. Sex:

• Male

41 (69.5%)

3. BMI “kg/m2” mean ± SD (range)

27.84 ± 4.42 (19.4–39.1)

4. Diabetes mellitus:

• Yes

14(23.7%)

5. Treatment status:

• Naïve

54(91.5%)

• INF experienced

5(8.5%)

6. HCV genotype

Genotype 4a (100%)

7. Baseline NS34A RASs

0 (0%)